In vitro efficacy of humanized regimen of flomoxef against extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae

This study compared the efficacy of flomoxef with other β-lactam antibiotics against extended-spectrum β-lactamases (ESBL)-producing bacteria of clinical relevance. First, the prevalence and β-lactamase genotypes of ESBL-producing strains among Escherichia coli and Klebsiella pneumoniae isolates col...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamashiro, Hidenori, Kasamatsu, Yu, Anan, Naomi, Takemura, Miki, Yamano, Yoshinori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2023
Materias:
Experimental Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508154/
https://www.ncbi.nlm.nih.gov/pubmed/37610203
http://dx.doi.org/10.1128/aac.00258-23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508154/
https://www.ncbi.nlm.nih.gov/pubmed/37610203
http://dx.doi.org/10.1128/aac.00258-23

Ejemplares similares